| 101 | CHEChemed Corp |
$2.5B |
10.5% |
2025 |
| 102 | TDOCTeladoc Health, Inc. |
$2.5B |
-7.9% |
2025 |
| 103 | AVAHAveanna Healthcare Holdings, Inc. |
$2.4B |
9.2% |
2026 |
| 104 | RPRXRoyalty Pharma plc |
$2.4B |
32.4% |
2025 |
| 105 | HIMSHims & Hers Health, Inc. |
$2.3B |
5.5% |
2025 |
| 106 | EXELExelixis, Inc. |
$2.3B |
33.7% |
2025 |
| 107 | NTRANatera, Inc. |
$2.3B |
-9.0% |
2025 |
| 108 | ENOVEnovis CORP |
$2.2B |
-52.7% |
2025 |
| 109 | ICUIIcu Medical Inc |
$2.2B |
0.0% |
2025 |
| 110 | SRPTSarepta Therapeutics, Inc. |
$2.2B |
-32.5% |
2025 |
| 111 | CONConcentra Group Holdings Parent, Inc. |
$2.2B |
7.7% |
2025 |
| 112 | PRVAPrivia Health Group, Inc. |
$2.1B |
1.1% |
2025 |
| 113 | QGENQiagen N.V. |
$2.1B |
20.3% |
2025 |
| 114 | RDNTRadNet, Inc. |
$2B |
-0.9% |
2025 |
| 115 | TFXTeleflex Inc |
$2B |
-45.4% |
2025 |
| 116 | EYENational Vision Holdings, Inc. |
$2B |
1.5% |
2025 |
| 117 | MRNAModerna, Inc. |
$1.9B |
-145.2% |
2025 |
| 118 | CLOVClover Health Investments, Corp. |
$1.9B |
-4.4% |
2025 |
| 119 | MDPediatrix Medical Group, Inc. |
$1.9B |
8.6% |
2025 |
| 120 | MSAMSA Safety Inc |
$1.9B |
14.9% |
2025 |
| 121 | ITGRInteger Holdings Corp |
$1.9B |
5.5% |
2025 |
| 122 | HCSGHealthcare Services Group Inc |
$1.8B |
3.2% |
2025 |
| 123 | PTCTPtc Therapeutics, Inc. |
$1.7B |
39.4% |
2025 |
| 124 | IARTIntegra Lifesciences Holdings Corp |
$1.6B |
-31.6% |
2025 |
| 125 | LNTHLantheus Holdings, Inc. |
$1.5B |
15.2% |
2025 |
| 126 | PAHCPhibro Animal Health Corp |
$1.5B |
6.6% |
2026 |
| 127 | NHCNational Healthcare Corp |
$1.5B |
7.9% |
2025 |
| 128 | MMSIMerit Medical Systems Inc |
$1.5B |
8.5% |
2025 |
| 129 | NUSNU Skin Enterprises, Inc. |
$1.5B |
10.8% |
2025 |
| 130 | ALKSAlkermes plc. |
$1.5B |
16.4% |
2025 |
| 131 | PIIIP3 Health Partners Inc. |
$1.5B |
-10.1% |
2024 |
| 132 | TRUPTrupanion, Inc. |
$1.4B |
1.4% |
2025 |
| 133 | LFSTLifeStance Health Group, Inc. |
$1.4B |
0.7% |
2025 |
| 134 | ADUSAddus HomeCare Corp |
$1.4B |
6.7% |
2025 |
| 135 | PENPenumbra Inc |
$1.4B |
12.7% |
2025 |
| 136 | HALOHalozyme Therapeutics, Inc. |
$1.4B |
22.7% |
2025 |
| 137 | LIVNLivaNova PLC |
$1.4B |
-17.5% |
2025 |
| 138 | CNMDCONMED Corp |
$1.4B |
3.4% |
2025 |
| 139 | HAEHaemonetics Corp |
$1.3B |
7.3% |
2026 |
| 140 | PGNYProgyny, Inc. |
$1.3B |
4.5% |
2025 |
| 141 | CURLFCuraleaf Holdings, Inc. |
$1.3B |
-18.2% |
2025 |
| 142 | INDVIndivior Pharmaceuticals, Inc. |
$1.2B |
16.9% |
2025 |
| 143 | NSRXNasus Pharma Ltd |
$1.2B |
-0.5% |
2025 |
| 144 | TECHBIO-TECHNE Corp |
$1.2B |
15.0% |
2026 |
| 145 | TRLVTrulieve Cannabis Corp. |
$1.2B |
-9.9% |
2025 |
| 146 | SHCSotera Health Co |
$1.2B |
6.7% |
2025 |
| 147 | NVAXNovavax Inc |
$1.1B |
39.2% |
2025 |
| 148 | PBHPrestige Consumer Healthcare Inc. |
$1.1B |
17.5% |
2026 |
| 149 | EMBCEmbecta Corp. |
$1.1B |
8.8% |
2025 |
| 150 | ACADAcadia Pharmaceuticals Inc |
$1.1B |
36.5% |
2025 |